Evidence map›Paper›PMID 25326580›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2015

HER2 activation results in β-catenin-dependent changes in pulmonary epithelial permeability.

James H Finigan, Vihas T Vasu, Jyoti V Thaikoottathil, Rangnath Mishra, Mohammad A Shatat, Robert J Mason, Jeffrey A Kern

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Air pollution-induced airway epithelial barrier dysfunction in COPD: a narrative review of mechanisms and therapeutic implications.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Article
  3. Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  4. Article
  5. Role of mTOR As an Essential Kinase in SCLC.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2020
    Article
  6. Article
  7. Interleukin-6 is required for Neuregulin-1 induced HER2 signaling in lung epithelium.Biochemical and biophysical research communications · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Cigarette Smoke Induces Human Epidermal Receptor 2-Dependent Changes in Epithelial Permeability.American journal of respiratory cell and molecular biology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

James H FiniganDivision of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, Colorado; Division of Oncology, National Jewish Health, Denver, Colorado; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Denver, Colorado FiniganJ@NJHealth.org.
Vihas T VasuDivision of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, Colorado;
Jyoti V ThaikoottathilDivision of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, Colorado;
Rangnath MishraDivision of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, Colorado;
Mohammad A ShatatDivision of Pulmonary, Critical Care and Sleep Medicine, Case Western Reserve University and the Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio; and.
Robert J MasonDivision of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, Colorado; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Denver, Colorado.
Jeffrey A KernDivision of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, Colorado; Division of Oncology, National Jewish Health, Denver, Colorado; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Denver, Colorado.
University of Colorado Denver · USNational Jewish Health · USCase Western Reserve University · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Tissue Bank and Biomarkers CoreP50CA058187 · NCI · UNIVERSITY OF COLORADO DENVER · PI MILLER, YORK E · 1992 to 2018
$43.8M
ADAM17-NRG-1 Signaling in Acute Lung InjuryR01HL111674 · NHLBI · NATIONAL JEWISH HEALTH · PI FINIGAN, JAMES H · 2012 to 2016
$1.9M
Air/liquid interface cultures for alveolar type II cell differentiationR21HL106112 · NHLBI · NATIONAL JEWISH HEALTH · PI MASON, ROBERT JAMES · 2011 to 2012
$436k
NCI NIH HHS P30 CA046934NCI NIH HHS P50 CA058187NHLBI NIH HHS HL106112NHLBI NIH HHS HL111674NHLBI NIH HHS R01 HL111674
6 · The paper itself

Abstract

The receptor tyrosine kinase human epidermal growth factor receptor-2 (HER2) is known to regulate pulmonary epithelial barrier function; however, the mechanisms behind this effect remain unidentified. We hypothesized that HER2 signaling alters the epithelial barrier through an interaction with the adherens junction (AJ) protein β-catenin, leading to dissolution of the AJ. In quiescent pulmonary epithelial cells, HER2 and β-catenin colocalized along the lateral intercellular junction. HER2 activation by the ligand neuregulin-1 was associated with tyrosine phosphorylation of β-catenin, dissociation of β-catenin from E-cadherin, and decreased E-cadherin-mediated cell adhesion. All effects were blocked with the HER2 inhibitor lapatinib. β-Catenin knockdown using shRNA significantly attenuated neuregulin-1-induced decreases in pulmonary epithelial resistance in vitro. Our data indicate that HER2 interacts with β-catenin, leading to dissolution of the AJ, decreased cell-cell adhesion, and disruption of the pulmonary epithelial barrier.

Indexed as

Adherens Junctionsbeta CateninCell AdhesionCell LineElectric ImpedanceEnzyme ActivationErb-b2 Receptor Tyrosine KinasesHumansLapatinibLungNeuregulin-1PermeabilityPhosphorylationProtein Kinase InhibitorsQuinazolinesRespiratory Mucosabeta CateninERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesLapatinibNeuregulin-1Protein Kinase InhibitorsQuinazolinesRNA, Small Interferingadherens junctioncell adhesionepithelial cellhuman epidermal growth factor receptor-2neuregulin-1permeabilityreceptor tyrosine kinaseβ-catenin

Identifiers

PMID25326580
PMCPMC4338945
OpenAlexW2016586043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.